NUVL Q1 2025 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena

NUVLNuvalent, Inc.

$8B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$95M

Net Income

-$85M

EPS (Diluted)

$-1.18

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$55M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$95M

Stockholders' Equity

$1.0B

Cash & Equivalents

$121M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$95M	-$53M	-80.3%
Net Income	-$85M	-$44M	-90.1%